Ovarian cancer metastasis: Looking beyond the surface.
Bayraktar E, Chen S, Corvigno S, Liu J, Sood AK.
Cancer Cell. 2024 Oct 14;42(10):1631-1636. doi: 10.1016/j.ccell.2024.08.016. Epub 2024 Sep 12.
HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Buza N.
Int J Gynecol Pathol. 2021 Jan;40(1):17-23. doi: 10.1097/PGP.0000000000000711.
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C.
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
Voutsadakis IA.
Int J Gynecol Cancer. 2020 Oct;30(10):1619-1626. doi: 10.1136/ijgc-2019-000832. Epub 2019 Nov 27.
Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
Angarita AM, Cholakian D, Fader AN.
Expert Rev Anticancer Ther. 2015;15(8):893-9. doi: 10.1586/14737140.2015.1052411. Epub 2015 Jun 3.
CT features of serous surface papillary carcinoma of the ovary.
Kim HJ, Kim JK, Cho KS.
AJR Am J Roentgenol. 2004 Dec;183(6):1721-4. doi: 10.2214/ajr.183.6.01831721.
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study.
Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J; Consortium STIC focusgroup; Hermens RPMG, Steenbeek MP.
BJOG. 2024 Dec;131(13):1851-1861. doi: 10.1111/1471-0528.17919. Epub 2024 Jul 25.
Uterine serous carcinoma and uterine carcinosarcoma: molecular features, clinical advances, and emerging therapies.
Lee EK, Liu JF.
Clin Adv Hematol Oncol. 2024 Jul-Aug;22(6):301-310.
Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
Fader AN, Boruta D, Olawaiye AB, Gehrig PA.
Curr Opin Obstet Gynecol. 2010 Feb;22(1):21-9. doi: 10.1097/GCO.0b013e328334d8a3.
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.
Toboni M, Kurnit K, Erickson B, Powell M, Secord AA, Fader AN.
Int J Gynecol Cancer. 2025 Mar;35(3):101672. doi: 10.1016/j.ijgc.2025.101672. Epub 2025 Jan 30.
